A Chinese Hamster Ovary (CHO) cell line stably transfected with human 5HT1a receptor, nuclear factor of activated T-cell-beta lactamase (NFAT-BLA) reporter construct and the G-alpha-15 pathway coupling protein was used (Invitrogen, part K1083). Cells were cultured in T-175 sq cm Corning flasks (part 431080) at 37 deg C and 95% RH. The growth media consisted of Dulbecco's Modified Eagle's Media (Invitrogen, part 11965-092) containing 10% v/v heat inactivated dialyzed fetal bovine serum (Invitrogen, part 26400-044), 0.1 mM NEAA (Invitrogen, part 1114-050), 1 mM Sodium Pyruvate (Invitrogen, part 11360-070), 25 mM HEPES (Invitrogen, part 15630-080), 5 mM L-Glutamine (Invitrogen, part 25030-081), 600 ug/mL Geneticin (Invitrogen, part 10131-027), 3 ug/mL Blasticidin (Invitrogen, part R210-01) , Zeocin 50ug/ml (Invitrogen, part R-250-01) and 1x penicillin-streptomycin-neomycin (Invitrogen, part 15640-055). Prior to the assay, cells were suspended to a concentration of 0.625 million/milliliter in phenol red free Dulbecco's Modified Eagle's Media (Invitrogen, part 21063-029) containing 2% charcoal/dextran treated fetal bovine serum (Hyclone, part SH30068.03), 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, and 5 mM L-Glutamine. The assay began by dispensing 4 microliters of cell suspension to each test well of a 1536 well plate. Immediately after, 50 nL of test compound or DMSO control was added. Then, 1ul of 5-CT agonist challenge was added to test wells and negative control wells to a final concentration of 100 nanomolar. Plates were then incubated at 37 deg C in 5% CO2 for 4 hrs. After the incubation, 1 microliter/well of the GeneBLAzer's fluorescent substrate mixture (Invitrogen, LiveBLAzer, part K1096), prepared according to the manufacturer's protocol and containing 200 mM probenicid (Sigma, part P8761) was added. After 1 hour of incubation at room temperature, plates were read on the EnVision plate reader (PerkinElmer Lifesciences, Turku, Finland) at an excitation wavelength 405 nm and emission wavelengths of 535 nm & 460 nm. Each channel of raw data was corrected by subtracting ""background"" (i.e. wells containing media and substrate only) before the ratio of 460 nm/535 nm fluorescence emission was calculated. Percent inhibition was calculated from the median ratio of the positive control after subtracting the negative control signal ratio from the sample well and the positive control. Percent inhibition was calculated from the median ratio as follows: % Inhibition= ((test_compound- median_negative_control)/( median_positive_control - median_negative_control))*100 The negative control wells were treated with challenge only (EC80 5-CT) and the positive controls wells were treated with the IC100 of WAY-100635 (50 nanomolar) in the presence of 5-CT challenge. The percent inhibition for each well has been calculated as follows: %inhibition = (test_compound - median_ negative_control)/(median_positive_control - median_negative_control)*100 where the positive control is Y-27632 (13 micromolar) and negative control is DMSO only.
bao:BAO_0000541 "571" ; # "is counter assay of" -> "571"
bao:BAO_0000812 "1675" ; # "has summary assay" -> "1675"
bao:BAO_0000210 bao:BAO_0000032 ; # "has assay stage" -> "secondary assay"
bao:BAO_0001070 bao:BAO_0001064 ; # "has alternate target assay" -> "alternate target assay"
bao:BAO_0000205 bao:BAO_0000219 ; # "has assay format" -> "cell-based format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000284 ; # "has participant" -> "G protein coupled receptor" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 "beta lactamase reporter gene" ; # "is bioassay type of" -> "beta lactamase reporter gene"
bao:BAO_0000212 bao:BAO_0000125 ; # "has assay method" -> "reporter gene method"
bao:BAO_0000212 bao:BAO_0000151 ; # "has assay method" -> "beta lactamase induction"
bao:BAO_0000207 bao:BAO_0000001 ; # "has detection method" -> "fluorescence resonance energy transfer"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Antagonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5-HT1E)" ; # "screening campaign name" -> "Antagonists of the 5-Hydroxytryptamine Receptor Subtype 1E (5-HT1E)"
bao:BAO_0002853 "Primary HTS assay for 5-Hydroxytryptamine (Serotonin) Receptor Subtype 1a (5HT1a) antagonists" ; # "has assay title" -> "Primary HTS assay for 5-Hydroxytryptamine (Serotonin) Receptor Subtype 1a (5HT1a) antagonists"
bao:BAO_0002854 bao:BAO_0000010 ; # "has bioassay type" -> "functional"
bao:BAO_0002867 bao:BAO_0000516 ; # "has assay footprint" -> "1536 well plate"
bao:BAO_0002863 bao:BAO_0000536 ; # "has concentration throughput" -> "single concentration"
bao:BAO_0000109 "37 degree celsius" ; # "has temperature value" -> "37 degree celsius"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "25 degree celsius" ; # "substrate incubation temperature" -> "25 degree celsius"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "1 hour" ; # "substrate incubation time" -> "1 hour"
bao:BAO_0002833 "4 hour" ; # "has incubation time value" -> "4 hour"
bao:BA0_0090012 bao:BAO_0000118 ; # "has participant" -> "DMSO"
bao:BAO_0000740 bao:BAO_0000080 ; # "has assay control" -> "positive control"
bao:BA0_0090012 "\"5-carboxamidotryptamine (5-CT) 100 nanomolar, 5-HT1A selective agonist\"" ; # "has participant" -> ""5-carboxamidotryptamine (5-CT) 100 nanomolar, 5-HT1A selective agonist""
bao:BAO_0000740 bao:BAO_0000079 ; # "has assay control" -> "negative control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "TSRI" ; # "material entity assay provider" -> "TSRI" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000373 ; # "has assay phase characteristic" -> "heterogeneous phase"
bao:BAO_0002000 bao:BAO_0000998 ; # "has measured entity" -> "Probenecid" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35222> ; # "has role" -> "inhibitor"
bao:BAO_0002000 bao:BAO_0000825 ; # "has measured entity" -> "5-Carboxamidotryptamine" || bao:BAO_0003102 bao:BAO_00020138 ; # "has role" -> "potentiator"
bao:BA0_0090012 "5-hydroxytryptamine receptor 1A" ; # "has participant" -> "5-hydroxytryptamine receptor 1A"
bao:BAO_0002004 <http://purl.obolibrary.org/obo/CLO_0002421> ; # "has cell line" -> "CHO cell"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "P08908" ; # "uniprot ID" -> "P08908"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10% v/v heat inactivated dialyzed fetal bovine serum" ; # "material entity culture serum" -> "10% v/v heat inactivated dialyzed fetal bovine serum" || bao:BAO_0003102 bao:BAO_0002596 ; # "has role" -> "culture serum"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "\"DMEM with 10% v/v heat inactivated dialyzed fetal bovine serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, 5 mM L-Glutamine, 600 microg/mL Geneticin, 3 microg/ml Blasticidin, 50 microg/ml Zeocin, and 1x penicillin-streptomycin-neomycin\"" ; # "material entity culture medium" -> ""DMEM with 10% v/v heat inactivated dialyzed fetal bovine serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, 5 mM L-Glutamine, 600 microg/mL Geneticin, 3 microg/ml Blasticidin, 50 microg/ml Zeocin, and 1x penicillin-streptomycin-neomycin"" || bao:BAO_0003102 bao:BAO_0000114 ; # "has role" -> "culture medium"
bao:BAO_0002922 "\"phenol red free DMEM with 2% charcoal/dextran treated fetal bovine serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, and 5 mM L-Glutamine\"" ; # "has assay medium" -> ""phenol red free DMEM with 2% charcoal/dextran treated fetal bovine serum, 0.1 mM NEAA, 1 mM Sodium Pyruvate, 25 mM HEPES, and 5 mM L-Glutamine""
bao:BAO_0002922 bao:BAO_0000596 ; # "has assay medium" -> "assay medium"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2% charcoal/dextran treated fetal bovine serum" ; # "material entity assay serum" -> "2% charcoal/dextran treated fetal bovine serum"
bao:BAO_0002923 bao:BAO_0002597 ; # "has assay serum" -> "assay serum"
bao:BAO_0000212 bao:BAO_0000246 ; # "has assay method" -> "stable transfection"
bao:BAO_0000550 "\"Expressing the human 5HT1A receptor, G-alpha-15 and beta-lactamase (BLA) gene under the control of the NFAT promoter (NFAT-BLA)\"" ; # "DNA construct" -> ""Expressing the human 5HT1A receptor, G-alpha-15 and beta-lactamase (BLA) gene under the control of the NFAT promoter (NFAT-BLA)""
bao:BAO_0003105 "\"5-hydroxytryptamine (seratonin) receptor 1A, G protein-coupled\"" ; # "has function" -> ""5-hydroxytryptamine (seratonin) receptor 1A, G protein-coupled""
bao:BAO_0003105 "\"guanine nucleotide binding protein (G protein), alpha 15 (Gq class)\"" ; # "has function" -> ""guanine nucleotide binding protein (G protein), alpha 15 (Gq class)""
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "3350" ; # "construct gene ID" -> "3350"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2769" ; # "construct gene ID" -> "2769"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0003105 bao:BAO_00020151 ; # "has function" -> "artificial regulatory region"
bao:BAO_0003105 "Nuclear factor of activated T-cells" ; # "has function" -> "Nuclear factor of activated T-cells"
bao:BAO_0003105 bao:BAO_0000751 ; # "has function" -> "Beta-lactamase" || bao:BAO_0003102 bao:BAO_0002656 ; # "has role" -> "reporter gene"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BA0_0090012 bao:BAO_0000751 ; # "has participant" -> "Beta-lactamase"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BAO_0000308 bao:BAO_0000958 ; # "has assay kit" -> "LiveBLAzer FRET - B/G Loading Kit"
bao:BAO_0000308 bao:BAO_0000248 ; # "has assay kit" -> "assay Kit"
bao:BAO_0000737 bao:BAO_0000677 ; # "has manufacturer" -> "Invitrogen" || bao:BAO_0003102 bao:BAO_0002626 ; # "has role" -> "biologics and screening manufacturer"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0000648 bao:BAO_0000733 ; # "compound library" -> "MLSMR library"
bao:BAO_0002865 bao:BAO_0000701 ; # "uses detection instrument" -> "EnVision Multilabel Reader"
bao:BAO_0000737 bao:BAO_0000297 ; # "has manufacturer" -> "Perkin Elmer" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0002917 "405 nanometer" ; # "has excitation wavelength value" -> "405 nanometer"
bao:BAO_0002918 "460 nanometer" ; # "has emission wavelength value" -> "460 nanometer"
bao:BAO_0002918 "535 nanometer" ; # "has emission wavelength value" -> "535 nanometer"
bao:BAO_0000337 bao:BAO_0000201 ; # "has percent response" -> "percent inhibition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "1" ; # "PubChem TID" -> "1"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002666 "10" ; # "has concentration value" -> "10"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
bao:BAO_0002787 "1" ; # "has concentration-point number" -> "1"
bao:BAO_0002845 "1" ; # "has repetition point-number" -> "1"
bao:BAO_0000196 bao:BAO_0000441 ; # "has mode of action" -> "competitive binding"
bao:BAO_0002864 bao:BAO_0000136 ; # "has repetition throughput" -> "single repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "mp" ; # "Annotated by" -> "mp"
